Shimadzu Corporation invested in Persist AI Formulation Corp (Persist AI, based in California) through the Corporate Venture Capital (CVC) fund “Shimadzu Future Innovation Fund” (Shimadzu FIF). The company is developing a platform that utilizes AI and robotics to streamline the formulation of pharmaceuticals. The formulation process, which involves processing the pharmaceutical active ingredients into useful […]

UPPSALA, Sweden — MAGic BioProcessing (Lab-on-a-Bead AB) is pleased to announce the appointment of Jonathan Royce to its Board of Directors. Jonathan is a seasoned C-suite leader with over 25 years of leadership experience in the life sciences sector, with a strong track record spanning industrial biotechnology, development, production, and commercial strategy. He has lead teams at organizations […]

Superior sensitivity broadens the dynamic range and improves detection limits, enabling accurate measurement of low molecular weight and low-abundance analytes Compatibility with 384-well plate increases throughput and enables sample volumes as small as 40 µL, reducing cost of analysis per sample Advanced evaporation control in the 96-well plate format preserves sample integrity, allowing for extended […]

Shimadzu Corporation has invested in U.S. startup SUN METALON Inc. (Sun Metalon, Illinois) through its corporate venture capital (CVC) fund, “Shimadzu Future Innovation Fund”. Sun Metalon is developing solution to recycle scrap metal generated by the automotive, construction machinery, and steel manufacturing industries at the sites. Despite its potential value, scrap metal generated at manufacturing […]

On Wednesday, May 21 2025, ORYL Photonics introduces the ORYL F1, a novel automated laser-based platform for the measurement of solubility and aggregation of drug molecules in the Life Science industry. This is a significant achievement for the fast-growing Swiss company and for the solubility and aggregation community. The laboratory instrument enables researchers to make […]

At today’s meeting, the Supervisory Board of Sartorius AG resolved to extend the appointment of Dr.  Alexandra Gatzemeyer as a member of the Executive Board by a five-year period to April 30, 2031. Gatzemeyer, who holds a Ph.D. in chemistry and pharmacology, has been with Sartorius since 2004 and was appointed to the Executive Board in March 2023. […]

MILFORD, Mass. — Waters Corporation (NYSE:WAT) today announced that it has acquired Halo Labs™, an innovator of specialized imaging technologies to detect, identify, and count interfering materials (particles) in therapeutic products, such as cell, protein, and gene therapies. The Aura™ platform from Halo Labs features a highly differentiated technology that performs full spectrum particle analysis and […]

Global life-sciences and financial leaders bring decades of health-care, biopharma, and strategic expertise to support Agilent’s next phase of growth SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced that Pascal Soriot, CEO of AstraZeneca, and Judy Gawlik Brown, founder and CEO of Downtown Advisory, have been elected to its Board of Directors, […]

FOSTER CITY, Calif. — Signios Biosciences (“Signios Bio”), a science-first biotechnology company leading in multiomics and AI-powered bioinformatics, in collaboration with Illumina, announced today an Illumina-sponsored grant for Early Access to Illumina Protein Prep 9.5K™. Powered by SOMAmer® technology, this next-generation sequencing (NGS)-based platform enables comprehensive proteomic profiling of plasma and serum. Illumina Protein Prep 9.5K™ utilizes slow […]

Morpho Biotech announces it has signed a distribution agreement with MACHEREY-NAGEL (MN) to distribute their Bioanalysis portfolio in the Netherlands as of July 1st. MN is an innovative international company for chemical and biomolecular analysis. The Bioanalysis portfolio of MN consists of efficient and reliable kits for RNA, DNA and protein purification from various sample […]